Amgen Inc Stock Net Income
| AMGN Stock | ARS 18,000 50.00 0.28% |
As of the 22nd of February, Amgen shows the risk adjusted performance of 0.0626, and Mean Deviation of 1.39. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amgen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amgen's valuation are provided below:Amgen Inc does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Amgen |
Amgen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amgen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amgen.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in Amgen on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Amgen Inc or generate 0.0% return on investment in Amgen over 90 days. Amgen is related to or competes with Verizon Communications, Lloyds Banking, and Agrometal SAI. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide More
Amgen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amgen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amgen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.8 | |||
| Information Ratio | 0.032 | |||
| Maximum Drawdown | 9.96 | |||
| Value At Risk | (2.79) | |||
| Potential Upside | 3.13 |
Amgen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amgen's standard deviation. In reality, there are many statistical measures that can use Amgen historical prices to predict the future Amgen's volatility.| Risk Adjusted Performance | 0.0626 | |||
| Jensen Alpha | 0.1555 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.034 | |||
| Treynor Ratio | (0.39) |
Amgen February 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0626 | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 1.39 | |||
| Semi Deviation | 1.56 | |||
| Downside Deviation | 1.8 | |||
| Coefficient Of Variation | 1346.17 | |||
| Standard Deviation | 1.91 | |||
| Variance | 3.63 | |||
| Information Ratio | 0.032 | |||
| Jensen Alpha | 0.1555 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.034 | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 9.96 | |||
| Value At Risk | (2.79) | |||
| Potential Upside | 3.13 | |||
| Downside Variance | 3.23 | |||
| Semi Variance | 2.44 | |||
| Expected Short fall | (1.57) | |||
| Skewness | 0.7001 | |||
| Kurtosis | 2.86 |
Amgen Inc Backtested Returns
At this point, Amgen is very steady. Amgen Inc secures Sharpe Ratio (or Efficiency) of 0.0585, which signifies that the company had a 0.0585 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Amgen Inc, which you can use to evaluate the volatility of the firm. Please confirm Amgen's mean deviation of 1.39, and Risk Adjusted Performance of 0.0626 to double-check if the risk estimate we provide is consistent with the expected return of 0.11%. Amgen has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Amgen are expected to decrease at a much lower rate. During the bear market, Amgen is likely to outperform the market. Amgen Inc right now shows a risk of 1.92%. Please confirm Amgen Inc semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if Amgen Inc will be following its price patterns.
Auto-correlation | -0.26 |
Weak reverse predictability
Amgen Inc has weak reverse predictability. Overlapping area represents the amount of predictability between Amgen time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amgen Inc price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Amgen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 510.2 K |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Amgen Inc reported net income of 5.75 B. This is much higher than that of the sector and significantly higher than that of the Net Income industry. The net income for all Argentina stocks is significantly lower than that of the firm.
Amgen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in net income category among its peers.
Amgen Fundamentals
| Return On Equity | 60.79 | |||
| Return On Asset | 9.13 | |||
| Profit Margin | 22.55 % | |||
| Operating Margin | 35.76 % | |||
| Current Valuation | 61.79 T | |||
| Shares Outstanding | 754.33 M | |||
| Price To Earning | 43.03 X | |||
| Price To Book | 9.73 X | |||
| Price To Sales | 12.67 X | |||
| Revenue | 25.48 B | |||
| Gross Profit | 19.27 B | |||
| EBITDA | 12.42 B | |||
| Net Income | 5.75 B | |||
| Cash And Equivalents | 8.08 B | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 32.78 B | |||
| Debt To Equity | 3.98 % | |||
| Current Ratio | 1.31 X | |||
| Cash Flow From Operations | 9.56 B | |||
| Earnings Per Share | 8.00 X | |||
| Number Of Employees | 24.3 K | |||
| Beta | 0.67 | |||
| Market Capitalization | 271.93 B | |||
| Z Score | 4.8 | |||
| Last Dividend Paid | 5.7 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.